Cetirizine
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
A second-generation (non-sedating) antihistamine used for the relief of symptoms associated with seasonal and perennial allergic rhinitis and chronic idiopathic urticaria. The active carboxylate metabolite of hydroxyzine, cetirizine has minimal CNS penetration compared to first-generation antihistamines, though it is slightly more sedating than other second-generation agents (loratadine, fexofenadine). Available over-the-counter.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
A second-generation (non-sedating) antihistamine used for the relief of symptoms associated with seasonal and perennial allergic rhinitis and chronic idiopathic urticaria. NutriStack rates the supporting evidence as strong. Common adult dosing is Adults and children >=6 years: 5-10 mg once daily; children 2-5 years: 2.5 mg daily (may increase to 5 mg/day); some patients benefit from 5 mg BID (as prescribed by your physician), though a prescriber sets the actual dose. This profile indexes 11 sources.
The bottom line
Evidence rating strong. Most-documented uses: relieves sneezing, rhinorrhea, itchy/watery eyes, treats seasonal and perennial allergic rhinitis, treats chronic idiopathic urticaria (hives). 11 sources indexed (2005–2024), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Selectively and competitively blocks peripheral H1 histamine receptors with minimal anticholinergic and anti-serotonergic effects. Inhibits the early-phase allergic response by preventing histamine from binding to H1 receptors on smooth muscle, vascular endothelium, and sensory nerve endings. Also inhibits eosinophil chemotaxis and late-phase allergic inflammatory mediator release at therapeutic doses. Minimal CNS penetration due to its zwitterionic properties and P-glycoprotein efflux at the blood-brain barrier.
Dosing & protocol.
Rapidly absorbed with bioavailability >70%. Food delays but does not reduce total absorption. Can be taken with or without food. May cause more drowsiness than loratadine or fexofenadine.
Full safety detail.
Side effects
- Drowsiness/somnolence (more common than other second-gen antihistamines, ~14%)
- Dry mouth
- Fatigue
- Headache
- Pharyngitis
- Abdominal pain
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
4- 1Topical cetirizine for treating androgenetic alopecia: A systematic reviewPMIDChen X, Xiang H, Yang M · Journal of cosmetic dermatology · 2022
Chen X, Xiang H, Yang M. Topical cetirizine for treating androgenetic alopecia: A systematic review. Journal of cosmetic dermatology. 2022
- 2Cetirizine for the treatment of allergic diseases in children: A systematic review and meta-analysisPMIDZhou P, Jia Q, Wang Z et al. · Frontiers in pediatrics · 2022
Zhou P, Jia Q, Wang Z et al.. Cetirizine for the treatment of allergic diseases in children: A systematic review and meta-analysis. Frontiers in pediatrics. 2022
- 3Placebo-controlled assessment of somnolence effect of cetirizine: a meta-analysisPMIDDu Q, Zhou Y · International forum of allergy & rhinology · 2016
Du Q, Zhou Y. Placebo-controlled assessment of somnolence effect of cetirizine: a meta-analysis. International forum of allergy & rhinology. 2016
- 4The fetal safety of cetirizine: an observational cohort study and meta-analysisPMIDEtwel F, Djokanovic N, Moretti ME et al. · Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology · 2014
Etwel F, Djokanovic N, Moretti ME et al.. The fetal safety of cetirizine: an observational cohort study and meta-analysis. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology. 2014
Randomized controlled trials
2- 5Randomized, placebo-controlled study of cetirizine and loratadine in children with seasonal allergic rhinitisPMIDNayak AS, Berger WE, LaForce CF et al. · Allergy and asthma proceedings · 2017
Nayak AS, Berger WE, LaForce CF et al.. Randomized, placebo-controlled study of cetirizine and loratadine in children with seasonal allergic rhinitis. Allergy and asthma proceedings. 2017
- 6Cetirizine and levocetirizine in the treatment of allergic rhinitis: a comparative studySource linkedPMIDCiprandi G, Cirillo I, Vizzaccaro A et al. · Allergy Asthma Proc · 2005
Reviews & position papers
1- 7High-risks drug adverse events associated with Cetirizine and Loratadine for the treatment of allergic diseases: A retrospective pharmacovigilance study based on the FDA adverse event reporting system databasePMIDKong W, Dong Y, Yi S et al. · Clinical and translational allergy · 2024
Kong W, Dong Y, Yi S et al.. High-risks drug adverse events associated with Cetirizine and Loratadine for the treatment of allergic diseases: A retrospective pharmacovigilance study based on the FDA adverse event reporting system database. Clinical and translational allergy. 2024
Reference material
4- 8Bousquet J et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy. 2008.Source linkedPMID
- 9Simons FE. Advances in H1-antihistamines. N Engl J Med. 2004.Source linkedPMID
- 10Zuberbier T et al. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022.Source linkedPMID
- 11Wellington K, Jarvis B. Cetirizine/pseudoephedrine. Drugs. 2001Source linkedPMID
Common questions.
Quick answers about Cetirizine, drawn from the data on this page.
What is Cetirizine?
A second-generation (non-sedating) antihistamine used for the relief of symptoms associated with seasonal and perennial allergic rhinitis and chronic idiopathic urticaria. The active carboxylate metabolite of hydroxyzine, cetirizine has minimal CNS penetration compared to first-generation antihistamines, though it is slightly more sedating than other second-generation agents (loratadine, fexofenadine). Available over-the-counter.
What is Cetirizine used for?
Commonly cited benefits of Cetirizine include: Relieves sneezing, rhinorrhea, itchy/watery eyes; Treats seasonal and perennial allergic rhinitis; Treats chronic idiopathic urticaria (hives); Once-daily dosing; Rapid onset of action (within 1 hour). NutriStack rates the overall evidence as strong.
What is a typical dose of Cetirizine?
A typical adult dose of Cetirizine is Adults and children >=6 years: 5-10 mg once daily; children 2-5 years: 2.5 mg daily (may increase to 5 mg/day); some patients benefit from 5 mg BID (as prescribed by your physician). The commonly recommended form is Oral tablets, chewable tablets, oral solution, or liquid gels. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Cetirizine?
Reported side effects include drowsiness/somnolence (more common than other second-gen antihistamines, ~14%), dry mouth, fatigue, headache, pharyngitis, abdominal pain. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Cetirizine?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Cetirizine in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.